Filgotinib: Product Overview

Definition:
Filgotinib is an oral Janus kinase 1 (JAK1) inhibitor developed for the treatment of inflammatory diseases. It specifically targets and blocks JAK1, a key enzyme involved in the signaling pathways of pro-inflammatory cytokines.

Function:
By inhibiting JAK1, Filgotinib modulates immune system activity, reducing inflammation and the associated symptoms of autoimmune conditions.

Applications:

· Rheumatoid Arthritis: Used to treat moderate to severe rheumatoid arthritis in adults who have not responded adequately to other treatments.

· Inflammatory Bowel Disease: Investigated for treating Crohn’s disease and ulcerative colitis.

· Other Autoimmune Diseases: Potential for treating additional inflammatory conditions, such as psoriatic arthritis.